Detalles de la búsqueda
1.
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer.
Breast Cancer Res Treat
; 192(1): 131-142, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34928481
2.
Clinical characteristics and genetic testing outcome of suspected hereditary peripheral nerve sheath tumours in a tertiary cancer institution in Singapore.
Hered Cancer Clin Pract
; 20(1): 23, 2022 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35698239
3.
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.
Breast Cancer Res Treat
; 188(2): 449-458, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909203
4.
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens.
Breast Cancer Res Treat
; 189(3): 665-676, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34553296
5.
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
BMC Cancer
; 20(1): 1118, 2020 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33203399
6.
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA).
Int J Gynecol Cancer
; 30(8): 1239-1242, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591370
7.
Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.
Gynecol Oncol
; 155(2): 275-279, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31481248
8.
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines.
Eur J Cancer
; 193: 113311, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37717281
9.
Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia.
Ther Adv Med Oncol
; 14: 17588359221139678, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36570409
10.
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.
Target Oncol
; 17(2): 141-151, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35195837
11.
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors.
Target Oncol
; 17(3): 355-368, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699834
12.
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.
Clin Cancer Res
; 28(11): 2248-2256, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35363275
13.
Infiltrative pattern of metastatic invasive lobular breast carcinoma in the abdomen: a pictorial review.
Insights Imaging
; 12(1): 181, 2021 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894297
14.
Nurse-Led Vital Signs Monitoring Can Safely Identify Low-Risk Hematology-Oncology Patients For De-Escalation.
JCO Oncol Pract
; 16(10): e1222-e1231, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574136
15.
The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience.
Endocr Relat Cancer
; 27(9): R307-R327, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32544879
16.
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique.
Cancers (Basel)
; 12(6)2020 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32560395
17.
Impact of deviation from guideline recommended treatment on breast cancer survival in Asia.
Sci Rep
; 10(1): 1330, 2020 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992769
18.
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.
Clin Cancer Res
; 26(17): 4494-4502, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32522887
19.
Discoveries beyond BRCA1/2: Multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world.
PLoS One
; 14(3): e0213746, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30875412
20.
Next Generation Sequencing Reveals Novel Mutations in Mismatch Repair Genes and Other Cancer Predisposition Genes in Asian Patients with Suspected Lynch Syndrome.
Clin Colorectal Cancer
; 18(4): e324-e334, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31350202